Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

AMIFAMPRIDINE vs AMIFOSTINE: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

AMIFAMPRIDINE vs AMIFOSTINE: Safety Overview

Metric AMIFAMPRIDINE AMIFOSTINE
Total FAERS Reports 2,424 125
Deaths Reported 203 7
Death Rate 8.4% 5.6%
Hospitalizations 680 35
Average Patient Age 62.5 yrs 53.3 yrs
% Female Patients 62.6% 45.4%
FDA Approval Date Nov 28, 2018 Dec 8, 1995
Manufacturer Catalyst Pharmaceuticals, Inc. N/A
Route ORAL N/A
Marketing Status Prescription Discontinued